Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
zestra, biotech stock review

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for...
Biotech Stock Review

Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry...

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Download Circle Group - Z-Trim Report

Circle Group Holdings (CRGQ) $0.47 Report.

Click to Download. Client, we were compensated with 100,000 shares and warrants to purchase...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...